Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12623000701628
Ethics application status
Approved
Date submitted
9/05/2023
Date registered
30/06/2023
Date last updated
30/06/2023
Date data sharing statement initially provided
30/06/2023
Type of registration
Prospectively registered
Titles & IDs
Public title
Opioid weaning program prior to total knee replacement
Query!
Scientific title
Implementation of an opioid weaning program prior to total knee replacement (TKR): feasibility and effect on postoperative outcomes
Query!
Secondary ID [1]
309258
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Opioid analgesia
329414
0
Query!
Knee oestoarthritis
329415
0
Query!
Condition category
Condition code
Anaesthesiology
326358
326358
0
0
Query!
Pain management
Query!
Anaesthesiology
326359
326359
0
0
Query!
Other anaesthesiology
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Participants in the active group of the study (those on the TKR surgery waitlist with with OMEDD
>30) will participate in the Empowered Relief (ER) program. ER is a two-hour education session that
will be delivered to groups of 10 study participants, either face to face or online. Face to face
sessions will be conducted at TQEH, and online sessions delivered via Zoom.
The session will be conducted by a Psychologist who is a certified ER Instructor. Participants will
receive the program approximately six months prior to surgery. Three ER sessions will be conducted
every six months over the course of the 2-year study period, to capture the full 110 patients
required for the study.
Content of the program includes:
• pain neuroscience education
• training in three core pain management skills: relaxation; cognitive reframing; self-soothing
techniques.
• development of a personalised plan for pain management.
Participants will also be supplied with the following patient-facing materials:
• a binaural audiofile (MP4) via the ER webpage for daily experience of the relaxation
response
• paper copy of the ER presentation slides
• paper copy of a pain survey for participants to self-identify their pain-related thoughts
• a form for recording their personalised plan for pain management
Neither the pain survey nor the personalised plan is collected by the ER Instructor; the patient-facing
materials are for the personal use of ER participants only. All ER materials are copyrighted and
internationally trademarked by Stanford University, and delivery of the certified program may not be
altered in any way.
Participants will complete a biopsychosocial screen when enrolling in the study, consisting of
DASS21, PCS, Revised Opioid Risk Tool, Oxford Knee Score, Knee Outcome Survey – Activities of Daily
Living, and Charlson comorbidity index, as per the study protocol. These will be administered and
scored by the Research Assistant. Immediately prior to surgery, all patients in the active group will
repeat the biopsychosocial screening measures, to allow pre-post comparison of the ER intervention
and weaning period. Participants will also complete a post-surgery satisfaction questionnaire
regarding the weaning program.
Query!
Intervention code [1]
325693
0
Behaviour
Query!
Intervention code [2]
325694
0
Treatment: Other
Query!
Comparator / control treatment
Control patients (who do not use opioid analgesia) will be used as a comparator given they will not recieve any of the above treatment.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
334214
0
Percentage of opioid tolerant patients who successfully wean opioid use greater than/equal to 50% prior to elective knee replacement. This will be collected via phone interview and data linked to prescriptions for each individual patient.
Query!
Assessment method [1]
334214
0
Query!
Timepoint [1]
334214
0
At time of surgery
Query!
Secondary outcome [1]
419858
0
Knee range of motion (ROM) post op day 1 onwards through admission and 3/6/12 months combined with 6 minute walk test (6MWT)
Query!
Assessment method [1]
419858
0
Query!
Timepoint [1]
419858
0
Collected daily by acute pain service (APS)/orthopaedic staff during inpatient stay. Completed by research staff/GP follow up at 3/6/12 month timepoints.
Query!
Secondary outcome [2]
422828
0
Cumulative postoperative opioid consumption - collected by APS team during inpatient stay from medical records
Query!
Assessment method [2]
422828
0
Query!
Timepoint [2]
422828
0
Daily totals from day 1 post operation until discharge
Query!
Secondary outcome [3]
422831
0
Hospital length of stay (in days) (from medical records)
Query!
Assessment method [3]
422831
0
Query!
Timepoint [3]
422831
0
Recorded at discharge.
Query!
Secondary outcome [4]
422832
0
Pain assessment from postoperative day 1 while in hospital. Measured as visual analogue scale (VAS) as a well validated and standardised scoring system.
Query!
Assessment method [4]
422832
0
Query!
Timepoint [4]
422832
0
Daily during inpatient admission until discharge
Query!
Secondary outcome [5]
422833
0
Oxford Knee Score (composite outcome as a validated knee specific questionaire for function)
Query!
Assessment method [5]
422833
0
Query!
Timepoint [5]
422833
0
At 3, 6 and 12 months from operation date by phone follow up and researcher review.
Query!
Secondary outcome [6]
422834
0
Surgical site and prosthetic joint infections (PJI)
Query!
Assessment method [6]
422834
0
Query!
Timepoint [6]
422834
0
Measured by phone follow up/medical records review at 12 months from operation.
Query!
Secondary outcome [7]
422835
0
Revision surgery rates at 1 year (recorded by research staff reviewing medical records)
Query!
Assessment method [7]
422835
0
Query!
Timepoint [7]
422835
0
At 12 months from operation date.
Query!
Secondary outcome [8]
422836
0
Prolonged opioid use at greater than 3 months from surgery date. Measured by phone call from research staff and patient reporting.
Query!
Assessment method [8]
422836
0
Query!
Timepoint [8]
422836
0
At 3 months from operation date.
Query!
Secondary outcome [9]
422837
0
Perceptions of the weaning program for all groups. Measured by Likert scale performed by research staff as phone interview.
Query!
Assessment method [9]
422837
0
Query!
Timepoint [9]
422837
0
At 1 month from operation date.
Query!
Secondary outcome [10]
423391
0
Functional activity score (FAS) to assess function as an outcome secondary to pain.
Query!
Assessment method [10]
423391
0
Query!
Timepoint [10]
423391
0
Daily assessment by APS team during admission.
Query!
Eligibility
Key inclusion criteria
- Prospective TKR patients using greater than/equal to 30mg oral morphine equivalent daily dose (oMEDD)
- At least 6 months prior to TKR at time of recruitment
- Willingness to engage with study and intervention
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Unwilling to engage with intervention
- Patient general practitioner unwilling to supervise opioid weaning process over course of study
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
-
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Three arms;
1. Opioid group who successfully wean at least 50% of their individual oMEDD at time of operation (Group W)
2. Opioid group who are not successful in weaning at least 50% of their individual oMEDD at time of operation (Group UW)
3. Control group who are not using opioid analgesia (Group C)
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
10/07/2023
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
28/06/2024
Query!
Actual
Query!
Date of last data collection
Anticipated
11/08/2025
Query!
Actual
Query!
Sample size
Target
110
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
SA
Query!
Recruitment hospital [1]
24366
0
The Queen Elizabeth Hospital - Woodville
Query!
Recruitment postcode(s) [1]
39950
0
5011 - Woodville
Query!
Funding & Sponsors
Funding source category [1]
313450
0
Charities/Societies/Foundations
Query!
Name [1]
313450
0
Australian and New Zealand College of Anaesthetists
Query!
Address [1]
313450
0
ANZCA House, 630 St Kilda Road
Melbourne, Victoria 3004 Australia
Query!
Country [1]
313450
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Central Adelaide Local Health Network
Query!
Address
28 Woodville Road, Woodville South, SA 5011
Query!
Country
Australia
Query!
Secondary sponsor category [1]
315290
0
None
Query!
Name [1]
315290
0
Query!
Address [1]
315290
0
Query!
Country [1]
315290
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
312653
0
Human Research Ethics Committee - Central Adelaide Local Health Network
Query!
Ethics committee address [1]
312653
0
CALHN Research Services | Central Adelaide Local Health Network Inc. | SA Health Level 3, Roma Mitchell Building | 136 North Terrace, Adelaide, SA 5000
Query!
Ethics committee country [1]
312653
0
Australia
Query!
Date submitted for ethics approval [1]
312653
0
29/03/2023
Query!
Approval date [1]
312653
0
04/04/2023
Query!
Ethics approval number [1]
312653
0
2022/HRE00263
Query!
Summary
Brief summary
Total knee replacement (TKR) rates in Australia have increased from 123 to 242 per 100,000 population from 2013-2016. By 2030, this is projected to rise by 276% (I. N. Ackerman et al., 2019; Adie, Harris, Chuan, Lewis, & Naylor, 2019). In the Central Adelaide Local Health Network, since July 2016, there has been 709 total knee replacements (both primary and revision) completed at The Queen Elizabeth Hospital (TQEH). The use of opioids before joint replacement surgery has been associated with poorer postoperative outcomes including both surgical site and periprosthetic infections, higher rates of early revision surgery, less improvement in pain/function, increase risk of persistent post discharge opioid use, longer stays in hospital and higher healthcare costs (Quinlan, Levy, Lobo, & Macintyre, 2021, Shadbolt et al., 2020, Adie et al., 2019). One in two Australian patients is prescribed an opioid in the year prior to joint replacement surgery (Inacio et al., 2018). On average over the last five years (2016-2021) TQEH completed approximately 140 TKR (both primary and revision operations) per year. Audit data from 2016-2021 at TQEH demonstrates that one in three (33%) of patients undergoing primary TKR (219/660) used preoperative opioid pain relief, with a median oral morphine equivalent daily dose (oMEDD) of 40mg. From 2016-2021 TQEH completed 49 revision TKRs with this patient population having a higher incidence of preoperative opioid use (24/49 or 48.9%) and the same median oral morphine equivalent daily dose of 40mg. This result underpins our decision to use oMEDDs of greater than or equal to 30mg for inclusion in the weaning protocol as detailed in the grant synopsis. This high incidence of opioid use within the health network likely has negative effects on patient outcomes as described above in literature examining other TKR patient populations. By designing and implementing a pathway for preoperative opioid weaning in patients presenting for TKR, we aim to improve outcomes without increasing preoperative pain. Opioid weaning in patients with chronic pain has been shown to be achievable with the majority of patients reporting the same or less pain. Implementing a slow, supervised taper from opioid analgesia poses minimal risk to patients (as opposed to rapid weaning), and as detailed below withdrawal symptoms will be monitored throughout the period of intervention. Should any patient experience withdrawal, they will be reverted to their previously tolerated dose and after a period of stabilisation be reintroduced to weaning at a lower intensity.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
125434
0
A/Prof Venkatesan Thiruvenkatarajan
Query!
Address
125434
0
The Queen Elizabeth Hospital
28 Woodville Road, Woodville South, SA 5011
Query!
Country
125434
0
Australia
Query!
Phone
125434
0
+61 0882226640
Query!
Fax
125434
0
Query!
Email
125434
0
[email protected]
Query!
Contact person for public queries
Name
125435
0
Venkatesan Thiruvenkatarajan
Query!
Address
125435
0
The Queen Elizabeth Hospital
28 Woodville Road, Woodville South, SA 5011
Query!
Country
125435
0
Australia
Query!
Phone
125435
0
+61 0882226000
Query!
Fax
125435
0
Query!
Email
125435
0
[email protected]
Query!
Contact person for scientific queries
Name
125436
0
Venkatesan Thiruvenkatarajan
Query!
Address
125436
0
The Queen Elizabeth Hospital
28 Woodville Road, Woodville South, SA 5011
Query!
Country
125436
0
Australia
Query!
Phone
125436
0
+61 0882226640
Query!
Fax
125436
0
Query!
Email
125436
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Private and potentially identifiable information
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF